MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Sherlock Raises $80M to Solve Diagnostic Barrier Dilemma

Image courtesy of Photology1971 / Alamy Stock Photo FETTKK.jpg
With this latest financing, the Boston, MA-based company has now raised a total of $111 million.

Sherlock Biosciences has raised $80 million in a financing to help enhance its point-of-care diagnostics offerings.

The series B round was led by Novalis LifeSciences and included new investors Illumina Ventures, Albany Capital and Catalio Capital Management, among others. They joined Northpond Ventures, Good Ventures, and other existing investors.

To date, the Boston, MA-based company has raised $111 million.

Powered by CRISPR and synthetic biology, Sherlock's proprietary engineering biology tools form the foundation of its decentralized diagnostic platform for DNA and RNA detection. This new funding will drive development of products and partnerships, enabled by this platform, that can operate at ambient temperature without complex instrumentation, opening up a wide range of applications in low resource settings including the home.

"Sherlock is dedicated to breaking down diagnostic barriers and bringing health information to people around the world," said Bryan Dechairo, President and CEO of Sherlock Biosciences. "Our novel chemistries combine the accuracy of PCR with the simplicity and convenience of antigen tests, powering a decentralized diagnostic platform for DNA and RNA detection. We are grateful to our funding partners for supporting our mission to ignite a convenience revolution in healthcare and further global public health."



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Find IVD Suppliers

Find suppliers of biochemicals, reagents, filters, membranes, assay system components, and contract manufacturing to the IVD sector on Qmed, the world's only director of pre-qualified suppliers to the medical device and diagnostics industry.